Oligonucleotide conjugated multi-functional adeno-associated viruses

Scientific Reports
Dhruva KatrekarPrashant Mali

Abstract

Recombinant adeno-associated viruses (AAVs) are among the most commonly used vehicles for in vivo gene delivery. However, their tropism is limited, and additionally their efficacy can be negatively affected by prevalence of neutralizing antibodies in sera. Methodologies to systematically engineer AAV capsid properties would thus be of great relevance. In this regard, we develop here multi-functional AAVs by engineering precision tethering of oligonucleotides onto the AAV surface, and thereby enabling a spectrum of nucleic-acid programmable functionalities. Towards this, we engineered genetically encoded incorporation of unnatural amino acids (UAA) bearing bio-orthogonal chemical handles onto capsid proteins. Via these we enabled site-specific coupling of oligonucleotides onto the AAV capsid surface using facile click chemistry. The resulting oligo-AAVs could be sequence specifically labeled, and also patterned in 2D using DNA array substrates. Additionally, we utilized these oligo conjugations to engineer viral shielding by lipid-based cloaks that efficaciously protected the AAV particles from neutralizing serum. We confirmed these 'cloaked AAVs' retained full functionality via their ability to transduce a range of cell types, ...Continue Reading

References

Feb 1, 1983·Journal of Virology·A SrivastavaK I Berns
Apr 1, 1998·Protein Science : a Publication of the Protein Society·R Furter
Sep 29, 1999·Journal of Medical Virology·K ErlesJ R Schlehofer
Apr 21, 2001·Science·L WangP G Schultz
Jul 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Qing XieMichael S Chapman
Aug 13, 1965·Science·R W ATCHISONW M HAMMON
Nov 19, 2004·Journal of the American Chemical Society·Nicholas J AgardCarolyn R Bertozzi
Jun 7, 2005·Biotechnology and Bioengineering·Gary K LeeDavid V Schaffer
Nov 15, 2005·The Journal of Gene Medicine·Luca PeraboHildegard Büning
Jan 24, 2006·Nature Biotechnology·Narendra MaheshriDavid V Schaffer
Mar 17, 2006·Nature·Paul W K Rothemund
Apr 5, 2007·Nature Protocols·Joshua C GriegerR Jude Samulski
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmela ZincarelliJoseph E Rabinowitz
Sep 20, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Erik S StroesJan Albert Kuivenhoven
Jan 13, 2009·The Journal of Infectious Diseases·Roberto CalcedoJames M Wilson
May 22, 2009·Nature·Shawn M DouglasWilliam M Shih
Jul 17, 2009·Journal of the American Chemical Society·Gary J TongMatthew B Francis
Aug 8, 2009·Science·Hendrik DietzWilliam M Shih
Mar 11, 2011·Bioconjugate Chemistry·Eric D HorowitzAravind Asokan
Sep 15, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kleopatra RaptiThomas Weber
Nov 10, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dawn E BowlesR Jude Samulski
Dec 14, 2011·The New England Journal of Medicine·Amit C NathwaniAndrew M Davidoff
Mar 23, 2012·The Journal of Clinical Endocrinology and Metabolism·André C CarpentierDaniel Gaudet
Sep 13, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert C MünchChristian J Buchholz
Dec 1, 2012·Science·Yonggang KePeng Yin
Dec 13, 2012·Angewandte Chemie·Xiangling XiongWeihong Tan
Mar 19, 2013·Nature Methods·Prashant MaliGeorge M Church
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Abhishek ChatterjeePeter G Schultz
May 21, 2014·Nature Reviews. Genetics·Melissa A Kotterman, David V Schaffer
Jul 6, 2014·Bioinformatics·Marc GüellGeorge M Church
Sep 10, 2014·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Caitlin M GuentherJunghae Suh
Jun 18, 2015·Nucleic Acids Research·Dong-Jiunn Jeffery TruongOskar Ortiz

❮ Previous
Next ❯

Citations

May 17, 2019·Essays in Biochemistry·Alexander R NödlingYu-Hsuan Tsai
Nov 5, 2019·Cancer Gene Therapy·Shuai Zhen, Xu Li
Aug 25, 2020·The CRISPR Journal·Lavina Sierra TayPrashant Mali
Feb 3, 2019·Nature Reviews. Drug Discovery·Dan WangGuangping Gao
May 2, 2020·Nature Communications·Jai Woong SeoKatherine W Ferrara
Oct 21, 2020·Nature Reviews. Drug Discovery·Elizabeth M PortoGene W Yeo
Nov 19, 2020·Chembiochem : a European Journal of Chemical Biology·Jonathan SchwachAndreas Stengl
Apr 4, 2021·Biomedicines·Fernando Cartón-GarcíaFernando Pastor
Jul 10, 2021·Frontiers in Cellular Neuroscience·Georg von JonquieresGary D Housley

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence imaging
DNA array
transfection
transfections
flow cytometry
PCR
Assay

Software Mentioned

Graphpad Prism
Cell Quest

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Chembiochem : a European Journal of Chemical Biology
Anne StrømgaardKristian Strømgaard
Journal of the American Chemical Society
Stephanie A FisherMolly S Shoichet
Proceedings of the National Academy of Sciences of the United States of America
Abhishek ChatterjeeP G Schultz
© 2022 Meta ULC. All rights reserved